title: Trial design, statins, atrial fibrillation, and prevention: four horsemen of the apocalypse.
authors.affiliation: Department of Cardiology, Faculty of Medicine, Atatürk University; Erzurum-Turkey. yavuzerkoza@hotmail.com.
authors.forename: Yavuzer
authors.initials: Y
authors.lastname: Koza
authors.forename: Ziya
authors.initials: Z
authors.lastname: Şimşek
authors.forename: Hakan
authors.initials: H
authors.lastname: Taş
authors.forename: Hüseyin
authors.initials: H
authors.lastname: Şenocak
mesh_terms: D000069059:Atorvastatin / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000517:prevention & control*; D001026:Coronary Artery Bypass; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000517:prevention & control*
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000069059:Atorvastatin